--2020/Q3-- / 0.000--
--2020/Q2-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Meta Platforms
META
Taiwan Semiconductor
TSM
Amazon
AMZN
Apple
AAPL
NVIDIA
NVDA
US Stock MarketDetailed Quotes
RLMD Relmada Therapeutics
- 2.770
- -0.520-15.81%
Close Dec 3 16:00 ET
- 2.830
- +0.060+2.17%
Post 20:01 ET
83.58MMarket Cap-968P/E (TTM)
3.250High2.760Low203.35KVolume3.250Open3.290Pre Close604.92KTurnover0.74%Turnover RatioLossP/E (Static)30.17MShares7.22352wk High1.76P/B76.29MFloat Cap1.88052wk Low--Dividend TTM27.54MShs Float54.000Historical High--Div YieldTTM14.89%Amplitude1.810Historical Low2.974Avg Price1Lot Size
Relmada Therapeutics Key Stats
Relmada Therapeutics Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 0 | 0 | 0 |
-- | -- | -- | |
| EPS | -0.64 | -0.72 | -0.08 |
| Miss Est. | +12.33% | +1.37% | -12.52% |
Analyst Rating
Nov 30, 2024
Relmada Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Relmada Therapeutics Earnings Reports
Read more
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data